217 related articles for article (PubMed ID: 32792229)
1. A review of urinary cytology in the setting of upper tract urothelial carcinoma.
Zhang ML; VandenBussche CJ; Hang JF; Miki Y; McIntire PJ; Peyton S; Vohra P
J Am Soc Cytopathol; 2021; 10(1):29-35. PubMed ID: 32792229
[TBL] [Abstract][Full Text] [Related]
2. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
3. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
[TBL] [Abstract][Full Text] [Related]
4. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
[TBL] [Abstract][Full Text] [Related]
5. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
6. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
Danakas A; Sweeney M; Cheris S; Agrawal T
J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
[TBL] [Abstract][Full Text] [Related]
7. The utility of upper urinary tract urine cytology before and after application of the Paris system.
Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
[TBL] [Abstract][Full Text] [Related]
8. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
Suo L; Vega I; Thrall M
J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based diagnostic accuracy measurement in urine cytology using likelihood ratios.
Myles N; Auger M; Kanber Y; Caglar D; Kassouf W; Brimo F
J Am Soc Cytopathol; 2021; 10(1):71-78. PubMed ID: 33071190
[TBL] [Abstract][Full Text] [Related]
10. High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology.
Renshaw AA; Gould EW
J Am Soc Cytopathol; 2021; 10(1):25-28. PubMed ID: 33132055
[TBL] [Abstract][Full Text] [Related]
11. High-grade urothelial carcinoma in urine cytology: different spaces - different faces, highlighting morphologic variance.
McIntire PJ; Elsoukkary SS; Robinson BD; Siddiqui MT
J Am Soc Cytopathol; 2021; 10(1):36-40. PubMed ID: 32958411
[TBL] [Abstract][Full Text] [Related]
12. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
[TBL] [Abstract][Full Text] [Related]
13. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
14. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
[TBL] [Abstract][Full Text] [Related]
15. Targeted education as a method for reinforcing Paris System criteria and reducing urine cytology atypia rates.
Compton ML; Weiss VL; Barkan GA; Ely KA
J Am Soc Cytopathol; 2021; 10(1):9-13. PubMed ID: 32771394
[TBL] [Abstract][Full Text] [Related]
16. Outcome analysis and negative predictive value of the "unsatisfactory/nondiagnostic" category of The Paris System for Reporting Urinary Cytology.
Abro S; Nomani L; Wojcik EM; Pambuccian SE; Chatt G; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):64-70. PubMed ID: 33279453
[TBL] [Abstract][Full Text] [Related]
17. Foreword: JASC urine cytology special edition.
Wojcik EM; Pambuccian SE; Rosenthal DL
J Am Soc Cytopathol; 2021; 10(1):1-2. PubMed ID: 33168474
[No Abstract] [Full Text] [Related]
18. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
[TBL] [Abstract][Full Text] [Related]
19. Urinary cytology with acridine orange fluorescence is highly valuable for predicting high-grade upper urinary tract urothelial carcinoma.
Li J; Zhang Z; Wang J; Zhang C; Li H; Xu Y
Int J Clin Exp Pathol; 2014; 7(2):774-8. PubMed ID: 24551302
[TBL] [Abstract][Full Text] [Related]
20. A new 7-point method facilitates accurate diagnosis of high-grade urothelial carcinoma in routine urinary cytology practice.
Iwai S; Mimura A; Ohtani H; Shimokama T; Kinjo M
J Am Soc Cytopathol; 2021; 10(1):103-109. PubMed ID: 33092994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
